Paper commissioned for the EFA Global Monitoring Report 2010, Reaching the marginalized
DHS Further Analysis Reports No. 100
Further Analysis of the 2000, 2005, and 2011 Demographic and Health Surveys. DHS Further Analysis Reports No. 79
Mejora del acceso a las tecnologías de apoyo para todos, en cualquier lugar
National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia
Lancet Public Health 2018 Published Online September 12, 2018 http://dx.doi.org/10.1016/ S2468-2667(18)30138-5
Urge una respuesta regional ante una crisis migratoria sin precedentes
Further analysis of the 1996, 2001, and 2006 Demographic and Health Surveys Data
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...ation and a recommendation on hydroxychloroquine. It follows the publication of six trials synthesized in a living network meta-analysis (NMA).
more
Updated Treatment Guidelines